Major depressive disorder Trials in Seattle, United States
Conditions / Major depressive disorder / Seattle, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
72 total trials for this combination
Showing top 10 of 72 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01085812 | Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06011577 | Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD | TERMINATED | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT04068467 | Evaluation of mHealth for Serious Mental Illness | COMPLETED | NA |
| NCT01567943 | Contingency Management of Alcohol Abuse in the Severely Mentally ILL | COMPLETED | NA |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT03481049 | Individualizing Incentives for Alcohol in the Severely Mentally Ill | COMPLETED | NA |
| NCT06002100 | Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements | ENROLLING_BY_INVITATION | — |
| NCT01157078 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |